Stock Market Falls, Recovers On Trump's Greenland Shifts; Intel, Netflix, Tesla Key Movers: Weekly Review

• The S&P 500 and Nasdaq fell below their 50-day moving averages Tuesday but recovered those key levels; the Russell 2000 continued leading with new record highs
• Interactive Brokers and Charles Schwab hit new highs after strong earnings, with IBKR reporting 27% EPS growth and 32% customer account increases; multiple regional banks rallied on solid results
• Intel guided weak for Q1 citing supply issues and failed to name new foundry customers, while Netflix's Q1 outlook disappointed with projected 15% growth vs. 16% in 2025; Tesla stock rose modestly ahead of Jan. 28 earnings

Market Summary: Weekly Review

Market Performance

The stock market experienced volatility during a holiday-shortened week, initially tumbling on President Trump's Greenland tariff threats before recovering as he reversed course. The small-cap Russell 2000 hit record highs, while the Nasdaq closed flat and the S&P 500 fell slightly. Both major indexes recovered from Tuesday's dip below their 50-day moving averages.

Key Earnings Winners

Interactive Brokers cleared Q4 views with 27% EPS growth and 17% revenue gains, driven by 22% higher commission revenue and 32% account growth. Charles Schwab reported 38% EPS growth with total client assets reaching a record $11.9 trillion.

Regional banks broadly rallied on strong results. U.S. Bancorp delivered 18% EPS growth, while Fifth Third and Zions posted 20% and 31% gains respectively.

Notable Earnings Disappointments

Intel beat Q4 estimates but provided weak Q1 guidance citing supply issues and failed to announce major foundry customers.

Netflix topped Q4 expectations with 30% EPS growth, but Q1 guidance (15% growth) and 2026 revenue outlook (13% vs. 16% in 2025) disappointed. The stock fell to 52-week lows.

Abbott Laboratories reported disappointing 3% organic growth—half analyst expectations—with Q1 guidance falling short.

GE Aerospace beat estimates but stock retreated on results.

Other Developments

Tesla removed safety monitors from select Austin robotaxis; Moderna stock surged on positive cancer vaccine trial results (49% death rate reduction); core PCE inflation held steady at 2.8%, potentially supporting Fed easing. The 10-year Treasury yield spiked Tuesday but retreated. Gold and silver continued advancing.